Early Hypertransaminasemia after Kidney Transplantation: Significance and Evolution According to Donor Type

por Eulàlia Solà-Porta, Dolores Redondo-Pachón, Carlos Arias-Cabrales, Diego Navazo, Anna Buxeda, Carla Burballa, Marta Crespo, Montserrat García-Retortillo, Julio Pascual, María José Pérez-Sáez
Publicado 2021

March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity

por Thiago J. Borges, Naoka Murakami, Felipe D. Machado, Ayesha Murshid, Benjamin J. Lang, Rafael L. Lopes, Laura M. Bellan, Mayuko Uehara, Krist H. Antunes, Maria José Pérez-Saéz, Gabriel Birrane, Priscila Vianna, João Ismael B. Gonçalves, Rafael F. Zanin, Jamil Azzi, Reza Abdi, Satoshi Ishido, Jeoung-Sook Shin, Ana Paula D. Souza, Stuart K. Calderwood, Leonardo V. Riella, Cristina Bonorino
Publicado 2018